Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human soluble Fc-gamma receptor IIb

EU orphan designation number: EU/3/07/462   
Active ingredient: Recombinant human soluble Fc-gamma receptor IIb
Indication: Treatment of idiopathic thrombocytopenic purpura
Sponsor: Baxalta Innovations GmbH
Industriestrasse 67, A-1221 Wien, Österreich

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/08/2007 Orphan designation EMEA/OD/028/07 (2007)3817 of 02/08/2007
01/10/2007 Corrigendum (2007)3817 cor of 27/09/2007
23/09/2013 Change of name and/or address of sponsor
12/06/2017 Transfer of orphan designation EMA/OD/028/07/T/01 (2017)4084 of 08/06/2017